Division of Translational Medicine and Human Genetics, Department of Medicine (X.B., S.S., P.C.L., Y.-A.K., D.J.R.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Department of Genetics (X.B., N.J.H., D.J.R.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Arterioscler Thromb Vasc Biol. 2022 Sep;42(9):1139-1151. doi: 10.1161/ATVBAHA.121.317156. Epub 2022 Jul 14.
Common genetic variation in close proximity to the gene are significantly associated with coronary artery disease as well as with plasma lipid traits. We recently demonstrated that hepatic inflammation and lipid regulator with ubiquitin-associated domain-like and NBR1-like domains (ILRUN) regulates lipoprotein metabolism in vivo in mice. However, whether ILRUN, which is expressed in vascular cells, directly impacts atherogenesis remains unclear. We sought to determine the role of ILRUN in atherosclerosis development in mice.
For our study, we generated global -deficient (KO) male and female mice on 2 hyperlipidemic backgrounds: low density lipoprotein receptor knockout (KO) and apolipoprotein E knockout (KO; double knockout [DKO]).
Compared with littermate control mice (single KO or KO), deletion of in DKO mice resulted in significantly attenuated both early and advanced atherosclerotic lesion development, as well as reduced necrotic area. DKO mice also had significantly decreased plasma cholesterol levels, primarily attributable to non-HDL (high-density lipoprotein) cholesterol. Hepatic-specific reconstitution of in DKO mice on the KO background normalized plasma lipids, but atherosclerotic lesion area and necrotic area remained reduced in DKO mice. Further analysis showed that loss of increased efferocytosis receptor MerTK expression in macrophages, enhanced in vitro efferocytosis, and significantly improved in situ efferocytosis in advanced lesions.
Our results support ILRUN as an important novel regulator of atherogenesis that promotes lesion progression and necrosis. It influences atherosclerosis through both plasma lipid-dependent and lipid-independent mechanisms. These findings support ILRUN as the likely causal gene responsible for genetic association of variants with coronary artery disease at this locus and suggest that suppression of ILRUN activity might be expected to reduce atherosclerosis.
基因附近的常见遗传变异与冠状动脉疾病以及血浆脂质特征显著相关。我们最近证明,具有泛素相关结构域和 NBR1 样结构域的肝内炎症和脂质调节因子(ILRUN)在体内调节小鼠的脂蛋白代谢。然而,血管细胞中表达的 ILRUN 是否直接影响动脉粥样硬化形成尚不清楚。我们试图确定 ILRUN 在小鼠动脉粥样硬化发展中的作用。
在两种高脂血症背景下,即低密度脂蛋白受体敲除(KO)和载脂蛋白 E 敲除(KO;双敲除 [DKO]),我们生成了全球缺失(KO)雄性和雌性小鼠:为我们的研究。
与同窝对照小鼠(单 KO 或 KO)相比,DKO 小鼠中 ILRUN 的缺失导致早期和晚期动脉粥样硬化病变发展明显减弱,以及坏死面积减少。DKO 小鼠的血浆胆固醇水平也显著降低,主要归因于非高密度脂蛋白(高密度脂蛋白)胆固醇。在 KO 背景下,DKO 小鼠肝脏特异性重建 ILRUN 可使血浆脂质正常化,但 DKO 小鼠的动脉粥样硬化病变面积和坏死面积仍减少。进一步分析表明,ILRUN 的缺失增加了巨噬细胞中吞噬作用受体 MerTK 的表达,增强了体外吞噬作用,并显著改善了晚期病变中的原位吞噬作用。
我们的结果支持 ILRUN 作为动脉粥样形成的重要新调节因子,促进病变进展和坏死。它通过依赖和不依赖脂质的机制影响动脉粥样硬化。这些发现支持 ILRUN 作为该基因座与冠状动脉疾病相关的变体的可能因果基因,并表明抑制 ILRUN 活性有望减少动脉粥样硬化。